TD Asset Management
GEVA

TD Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

TD Asset Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,300
Closed -$2.47M – 1448
2015
Q1 		$2.47M Buy
25,300
+14,600
+136% +$1.55M ﹤0.01% 803
2014
Q4 		$993K Buy
+10,700
New +$844K ﹤0.01% 935

TD Asset Management's GEVA Position: Q2 2015 in Review

TD Asset Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 25,300 shares — an estimated $2.47M sold.

TD Asset Management first reported a position in GEVA in Q4 2014 and held it in 2 quarters. The position peaked at $2.47M in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • TD Asset Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • TD Asset Management sold 25,300 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $2.47M.
  • TD Asset Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • TD Asset Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $2.47M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on TD Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.